Literature DB >> 8318653

Preparation of aflatoxin B1 8,9-epoxide using m-chloroperbenzoic acid.

R S Iyer1, T M Harris.   

Abstract

Aflatoxin B1 is a potent carcinogen which requires activation in order to react with DNA. The exo-8,9-epoxide is putatively the active form although it has thus far eluded direct detection in biological systems. This laboratory has reported a synthesis of the epoxide using dimethyldioxirane as the oxidant [(1988) J. Am. Chem. Soc. 110, 7929-7931]. A new, very convenient synthesis is described herein in which m-chloroperbenzoic acid is used as the oxidant in a two-phase system. The reaction is carried out in CH2Cl2 in contact with an aqueous phosphate buffer (pH 7.2) to remove the byproduct m-chlorobenzoic acid, which would otherwise react with the epoxide. Excess m-chloroperbenzoic acid is removed with aqueous sodium thiosulfate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318653     DOI: 10.1021/tx00033a010

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  4 in total

1.  Site-specific targeting of aflatoxin adduction directed by triple helix formation in the major groove of oligodeoxyribonucleotides.

Authors:  W R Jones; M P Stone
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

2.  Thiol-activated DNA damage by α-bromo-2-cyclopentenone.

Authors:  Mostafa I Fekry; Nathan E Price; Hong Zang; Chaofeng Huang; Michael Harmata; Paul Brown; J Scott Daniels; Kent S Gates
Journal:  Chem Res Toxicol       Date:  2011-01-20       Impact factor: 3.739

Review 3.  Advances in Antibody Preparation Techniques for Immunoassays of Total Aflatoxin in Food.

Authors:  Yanan Wang; Jinqing Jiang; Hanna Fotina; Haitang Zhang; Junjie Chen
Journal:  Molecules       Date:  2020-09-09       Impact factor: 4.411

4.  Simplified Synthesis and Stability Assessment of Aflatoxin B1-Lysine and Aflatoxin G1-Lysine.

Authors:  Justin B Renaud; Jacob P Walsh; Mark W Sumarah
Journal:  Toxins (Basel)       Date:  2022-01-14       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.